Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline
Authors:
- 1 February 2017
- journal article
- practice guideline
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 13 (2) , 123-127
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical TrialJournal of Clinical Oncology, 2013
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973–1991Journal of Neurosurgery, 1998
- Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after SurgeryNew England Journal of Medicine, 1980
- An analysis of dose-effect relationship in the radiotherapy of malignant gliomasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1979
- Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomasJournal of Neurosurgery, 1978
- The spread of glioblastoma multiforme as a determining factor in the radiation treated volumeInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1976
- Evaluation of mithramycin in the treatment of anaplastic gliomasJournal of Neurosurgery, 1976
- HOSPITAL FOR EPILEPSY AND PARALYSIS, REGENT'S PARK.The Lancet, 1884